Recombinant Human Thrombopoietin Recruiting Phase 4 Trials for Thrombocytopenia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03633019High-dose Use of rhTPO in CIT Patients